Item 2.02 Results of Operations and Financial Condition.

Explanatory Note:

On November 3, 2009, AGA Medical Holdings, Inc. (the "Company") issued a press release announcing its financial results for its quarter ended September 30, 2009 and filed a Current Report on Form 8-K (the "Prior Form 8-K") which included a copy of the earnings press release.

This Amendment No. 1 (this "Amendment") amends the Prior Form 8-K to correct an inadvertent error in the press release regarding the year in which the Company received a CE Mark for the AMPLATZER Vascular Plug 4. Specifically, the second bulleted statement on page one of the press release has been corrected to read as follows:

"Received CE Mark in July 2009 for the AMPLATZER Vascular Plug 4, which can be delivered through standard diagnostic catheters with the advantage of no additional cost or time required to exchange from a diagnostic catheter to a therapeutic delivery catheter, meaningfully expanding the addressable market for the Vascular Plug family."

A copy of the corrected press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

As provided in General Instruction B.2 of Form 8-K, the information and exhibits contained in this Current Report on Form 8-K/A shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description Exhibit 99.1 Press release dated November 3, 2009 (corrected)

---